#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac arrest Exudative retinopathy B-cell small lymphocytic lymphoma recurrent Squamous cell carcinoma of head and neck Solitary fibrous tumour Hypoparathyroidism Primary amyloidosis Follicle centre lymphoma follicular grade I, II – III Mucopolysaccharidosis II Metastases to central nervous system B-cell lymphoma Epstein-Barr virus infection Myxofibrosarcoma Epidermolysis bullosa Rectal cancer More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma Optic glioma Proteus syndrome – Basic Information Breast angiosarcoma metastatic – Basic Information Basal cell naevus syndrome – Basic Information Glycogen storage disease type I – Basic Information Burkitt’s lymphoma Mantle cell lymphoma – Treatment Sjogren’s syndrome – Trials in Disease Rhabdomyosarcoma – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tipapkinogene Sovacivec [99MTC]PSMA I&S Rilvegostomig Miransertib Octreotide Acetate Trientine Dihydrochloride Leuprorelin Acetate Water For Injections Raxtozinameran LY3372993 Rosuvastatin Zinc Mometasone Cefuroxime Cart 19/22 T Cells Sotalol Alectinib Carbasalate Calcium Elezanumab Azd5004 Fenoterol Hydrobromide More therapies…

    Learn about Your Condition

    Type V hyperlipidaemia Rhinitis allergic Peritoneal dialysis Rosai-Dorfman syndrome Cutaneous lupus erythematosus Renal cell carcinoma Arthroscopy Basal cell naevus syndrome Langerhans' cell histiocytosis Primary hyperthyroidism Electrocorticogram Transient ischaemic attack Blood iron increased Ovarian cancer Subdural haematoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Study of chemotherapy drug combination with or without heated chemotherapy in the abdomen for patients with advanced colon cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    • Colorectal cancer stage II
    • Colorectal cancer stage III
    Investigated Drugs:
    • Capecitabine
    • Fluorouracil
    • Folinic Acid
    Spain

  • Study of MT-501 in patients with active Crohn’s Disease or Ulcerative Colitis: A Phase 2 safety and effectiveness trial

    Recruiting

    2 1
    Investigated Diseases:
    • Colitis ulcerative
    • Crohn’s disease
    Belgium Bulgaria Croatia Czechia Germany Italy +2

  • Study of N-acetylcysteine and prednisolone combination versus extended prednisolone treatment in patients with severe alcoholic hepatitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hepatitis alcoholic
    Investigated Drugs:
    • Acetylcysteine
    • Prednisolone Metasulfobenzoate Sodium
    • Prednisolone
    France

  • Study of bevacizumab and trifluridine combination given bi-weekly to reduce severe neutropenia in patients with metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal adenocarcinoma
    Investigated Drugs:
    • Trifluridine
    • Bevacizumab
    France

  • Study of FOLFOX or FOLFIRI chemotherapy with fruquintinib or bevacizumab as second-line treatment for patients with metastatic colorectal cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer metastatic
    Investigated Drugs:
    • FRUQUINTINIB
    • Fluorouracil
    • Folinic Acid
    France

  • Study of intra-arterial angiotensin II during radioembolization to improve treatment effectiveness in patients with primary or secondary liver cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cancer
    Investigated Drugs:
    • ANGIOTENSIN II
    The Netherlands
Previous Page
1 … 4 5 6 7 8 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!